MDL For Kidney Injuries From Proton Pump Inhibitor Drugs Sought By Plaintiffs

Mealey's (October 27, 2016, 9:04 AM EDT) -- WASHINGTON, D.C. — Plaintiffs in six federal lawsuits on Oct. 17 moved for centralization of cases involving proton pump inhibitor (PPI) drugs and alleged kidney injury (In Re:  Proton-Pump Inhibitor Products...
To view the full article, register now.